| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Family-based Genetic Association Study of Variants in Estrogen-metabolism Genes COMT and CYP1B1 and Breast Cancer Risk
|
Habibul Ahsan
|
|
2004
|
85 |
2 |
p. 121-131
11 p.
|
artikel
|
| 2 |
A Family-based Genetic Association Study of Variants in Estrogen-metabolism Genes COMT and CYP1B1 and Breast Cancer Risk
|
Ahsan, Habibul
|
|
2004
|
85 |
2 |
p. 121-131
|
artikel
|
| 3 |
A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer
|
Gary H. Lyman
|
|
2004
|
85 |
2 |
p. 143-150
8 p.
|
artikel
|
| 4 |
A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer
|
Lyman, Gary H.
|
|
2004
|
85 |
2 |
p. 143-150
|
artikel
|
| 5 |
Hormonal Factors and Breast Tumor Proliferation: Do Factors that Affect Cancer Risk also Affect Tumor Growth
|
Nina Oestreicher
|
|
2004
|
85 |
2 |
p. 133-142
10 p.
|
artikel
|
| 6 |
Hormonal Factors and Breast Tumor Proliferation: Do Factors that Affect Cancer Risk also Affect Tumor Growth?
|
Oestreicher, Nina
|
|
2004
|
85 |
2 |
p. 133-142
|
artikel
|
| 7 |
Instructions for Authors
|
|
|
2004
|
85 |
2 |
p. 197-200
4 p.
|
artikel
|
| 8 |
Instructions for Authors
|
|
|
2004
|
85 |
2 |
p. 197-200
|
artikel
|
| 9 |
Naringenin Inhibits Glucose Uptake in MCF-7 Breast Cancer Cells: A Mechanism for Impaired Cellular Proliferation
|
Anne W. Harmon
|
|
2004
|
85 |
2 |
p. 103-110
8 p.
|
artikel
|
| 10 |
Naringenin Inhibits Glucose Uptake in MCF-7 Breast Cancer Cells: A Mechanism for Impaired Cellular Proliferation
|
Harmon, Anne W.
|
|
2004
|
85 |
2 |
p. 103-110
|
artikel
|
| 11 |
Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a Novel Active Metabolite of Tamoxifen
|
Michael D. Johnson
|
|
2004
|
85 |
2 |
p. 151-159
9 p.
|
artikel
|
| 12 |
Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a Novel Active Metabolite of Tamoxifen
|
Johnson, Michael D.
|
|
2004
|
85 |
2 |
p. 151-159
|
artikel
|
| 13 |
Regulation of the Estrogen Receptor α Minimal Promoter by Sp1, USF-1 and ERα
|
Linda A. deGraffenried
|
|
2004
|
85 |
2 |
p. 111-120
10 p.
|
artikel
|
| 14 |
Regulation of the Estrogen Receptor α Minimal Promoter by Sp1, USF-1 and ERα
|
deGraffenried, Linda A.
|
|
2004
|
85 |
2 |
p. 111-120
|
artikel
|
| 15 |
Updates on SABCS 2003 Abstracts
|
|
|
2004
|
85 |
2 |
p. 173-195
23 p.
|
artikel
|
| 16 |
Updates on SABCS 2003 Abstracts
|
|
|
2004
|
85 |
2 |
p. 173-195
|
artikel
|
| 17 |
VEGFDT385 Toxin Conjugate Inhibits Mammary Adenocarcinoma Development in a Transgenic Mouse Model of Spontaneous Tumorigenesis
|
R. Wild
|
|
2004
|
85 |
2 |
p. 161-171
11 p.
|
artikel
|
| 18 |
VEGF—DT385 Toxin Conjugate Inhibits Mammary Adenocarcinoma Development in a Transgenic Mouse Model of Spontaneous Tumorigenesis
|
Wild, R.
|
|
2004
|
85 |
2 |
p. 161-171
|
artikel
|
Tijdschrift beschrijving